Hims & Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting ...

We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the ...

A STAT analysis found more than 40 hospitals have paused or ceased to offer some gender-affirming care to young people since ...

As it seeks to crack down on health care fraud, the Trump administration has put entire states in its crosshairs, notably ...

Ocular Therapeutix and Eyepoint Pharmaceuticals are developing competing eye treatments, and the competition appears to be ...

Based on ads released in advance of the Super Bowl, little has changed in the eyes of the pharma industry since the FDA began ...

On Super Bowl Sunday, the drug industry is trotting out lounging football stars, a shouting DJ Khaled, and the soothing tones ...

Over two years after the approval of Vertex’s sickle cell treatment Casgevy, rollout has continued to be slow, with only ...

What drug ads will air during Sunday's Super Bowl? STATus Report host Alex Hogan and reporter at large Damian Garde have a ...

A newborn baby in New Mexico has died from listeria, likely in connection to the mother’s consumption of raw milk during ...

With shares down more than 40% since November, the risk-reward for Nektar Therapeutics has shifted ahead of pivotal clinical ...

During pre-submission meetings, the agency told Corcept on “several occasions” to “expect significant review issues” if it ...